Provided is a pharmaceutical agent for use in the treatment of inflammation, in a subject prone to and/or experiencing an excessive inflammatory response as a result of infection with an infectious agent and/or exposure to an allergen and/or exposure to an environmental trigger, which pharmaceutical agent comprises an agent for preventing, hindering, modulating or reducing: (a) the production, activity and/or effect of one or more cytokines； and/or (b) the functionality of one or more cells that are targets for the cytokines； and/or (c) a pathological effect caused by cells producing and/or activated by the cytokines.
